|
Name |
Cyclododecane
|
Molecular Formula | C12H24 | |
IUPAC Name* |
cyclododecane
|
|
SMILES |
C1CCCCCCCCCCC1
|
|
InChI |
InChI=1S/C12H24/c1-2-4-6-8-10-12-11-9-7-5-3-1/h1-12H2
|
|
InChIKey |
DDTBPAQBQHZRDW-UHFFFAOYSA-N
|
|
Synonyms |
CYCLODODECANE; 294-62-2; Cyclododecan; 97CN13ZD83; EINECS 206-033-9; HSDB 5557; BRN 1901008; UNII-97CN13ZD83; DSSTox_CID_1552; EC 206-033-9; CYCLODODECANE [HSDB]; DSSTox_RID_76206; DSSTox_GSID_21552; 4-05-00-00169 (Beilstein Handbook Reference); CHEMBL3185808; DTXSID9021552; Tox21_202734; MFCD00014258; ZINC54962163; AKOS006227986; NCGC00260282-01; AS-56381; CAS-294-62-2; DB-047586; CS-0155296; FT-0624163; D89269; Q118040
|
|
CAS | 294-62-2 | |
PubChem CID | 9268 | |
ChEMBL ID | CHEMBL3185808 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 168.32 | ALogp: | 6.7 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 12 | QED Weighted: | 0.471 |
Caco-2 Permeability: | -4.773 | MDCK Permeability: | 0.00001610 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.27 |
30% Bioavailability (F30%): | 0.992 |
Blood-Brain-Barrier Penetration (BBB): | 0.515 | Plasma Protein Binding (PPB): | 97.48% |
Volume Distribution (VD): | 3.22 | Fu: | 1.74% |
CYP1A2-inhibitor: | 0.7 | CYP1A2-substrate: | 0.203 |
CYP2C19-inhibitor: | 0.494 | CYP2C19-substrate: | 0.067 |
CYP2C9-inhibitor: | 0.149 | CYP2C9-substrate: | 0.94 |
CYP2D6-inhibitor: | 0.112 | CYP2D6-substrate: | 0.111 |
CYP3A4-inhibitor: | 0.138 | CYP3A4-substrate: | 0.058 |
Clearance (CL): | 3.944 | Half-life (T1/2): | 0.122 |
hERG Blockers: | 0.162 | Human Hepatotoxicity (H-HT): | 0.021 |
Drug-inuced Liver Injury (DILI): | 0.353 | AMES Toxicity: | 0.027 |
Rat Oral Acute Toxicity: | 0.044 | Maximum Recommended Daily Dose: | 0.043 |
Skin Sensitization: | 0.955 | Carcinogencity: | 0.075 |
Eye Corrosion: | 0.992 | Eye Irritation: | 0.971 |
Respiratory Toxicity: | 0.869 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000893 | 0.923 | D00SBN | 0.297 | ||||
ENC000323 | 0.833 | D08VSI | 0.253 | ||||
ENC000840 | 0.694 | D0N3PE | 0.246 | ||||
ENC001017 | 0.654 | D0S5NG | 0.244 | ||||
ENC001146 | 0.600 | D07XJM | 0.222 | ||||
ENC000251 | 0.500 | D09GFL | 0.217 | ||||
ENC001147 | 0.500 | D0L0MK | 0.208 | ||||
ENC001230 | 0.347 | D02LRQ | 0.181 | ||||
ENC000170 | 0.333 | D0R1WR | 0.181 | ||||
ENC005710 | 0.275 | D0U3CR | 0.179 |